Clinical Trial

Factors Associated With Acceptance of Home-Based Pulmonary Telerehabilitation in COPD

Study acronym: ACCEPT-TR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Pulmonary rehabilitation improves symptoms, exercise capacity, and quality of life in people with chronic obstructive pulmonary disease (COPD), but access and participation may be limited by travel, organizational, logistical, and personal barriers. Home-based pulmonary telerehabilitation may reduce some of these barriers, although not all eligible individuals accept this mode of care. Identifying the characteristics associated with acceptance or refusal of this model is therefore essential to better define the population most likely to benefit from this approach, tailor the program's delivery and content, and identify potential remaining barriers in order to improve access to care. This retrospective study will use existing data from adults with COPD who were screened at ADIR Association between May 2024 and April 2025 for an 8-week home-based pulmonary telerehabilitation feasibility study. Of 50 potentially eligible individuals, 21 accepted participation and 29 declined. Demographic, clinical, functional, psychological, and geographic characteristics will be compared between individuals who accepted and those who declined participation. Documented reasons for refusal will be described, and factors associated with refusal will be explored using logistic regression.
Trial Details
NCT Number NCT07747571
Lead Sponsor ADIR Association
Collaborators: University of Rouen Normandie, Hopital La Musse
Conditions Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Rehabilitation
Enrollment 50 participants
Start Date 2026-09-01
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10